« Older Home
Loading Newer »

Dekker to Fight Doping Charges

CyclingNews.com reports that Thomas Dekker is going to fight to clear his name. In comments attributed to an interview with Dutch newspaper De Telegraaf, Dekker said:

“This should not be the end of my cycling career,” he said.

“This is a very strange story,” Dekker told the Dutch newspaper De Telegraaf. When he returned after a final training ride before traveling to the Tour, he received a phone call from Anne Gripper, the UCI’s anti-doping manager. “She told me that I had tested positive for EPO in December 2007. I listened to the whole story. Then I just about hit the ground.”

The 24-year-old said that he finds it “all very strange. I do not know exactly what is going on.” Dekker also questioned the timing of the matter. “This story pops up on the very day that I leave for the Tour.

“How can a sample be negative in 2007 and now suddenly gets tested again? That is wrong.”

Then again, WADA tells a slightly different story, according to a Deutsche Presse-Agentur story at Monsters and Critics.com.

However, the World Anti-Doping Agency ordered the retest due to suspicious blood levels over the past month.

‘We have been watching Dekker for quite a while and conducted retests with new methods of his frozen samples in Cologne,’ said Enrico Carpani, spokesman of the ruling cycling body UCI.

According to CyclingNews.com, Dekker released a statement in which he claims to have a letter from Dr. Mario Zorzoli of the UCI which states:

“This is to confirm that all test results of 2008 that are known to the UCI show that the blood values of Thomas Dekker…did not exceed any limits which would have required the imposition of a declaration of incapability under UCI’s current regulations.”

Dekker contacted Zorzoli after rumors of irregularities in his blood tests surfaced in 2008. Zorzoli’s letter refers to tests conducted for the biological passport in 2008. Whether Dekker’s test results from an out-of-competition test conducted shortly before Christmas in 2007 may be another matter. Dekker, however, claims that Zorzoli’s letter proves that there were no problems with his blood values.

Dekker also takes issue with the retesting of urine samples. The retesting appears to have suggested that Dekker used Dynepo, a second-generation blood boosting drug based on EPO. ”It is now apparent to all that new standards are being applied to older, previously tested samples found to be negative,” the cyclist said.

The crux of the UCI’s allegations seems to stem from retesting of Dekker’s December 2007 urine sample. While the UCI is within their rights to retest a sample that is less than eight years old, and while Dekker’s biological passport data may have led to the retesting, one question remains: How did the lab conducting the original test results originally determine that the sample was negative for EPO and it’s related drugs, and how did they then come to a different conclusion at this time?

It’s not as if Dynepo wasn’t detectable back in December 2007. It was. So the lab should have caught Dekker’s use on the first go `round (assuming that Dekker was actually using the drug). Is this, as Dekker claims, a case where standards were lowered in order to “catch” more cheats? And if so, what it the scientific basis for lowering those standards.

Whatever the answers to those questions, I hope Dekker has a lot of money to spend. As we saw in a previous case, the anti-doping authorities are not hesitant to spend whatever it takes (and do whatever it takes) to win a doping conviction. Before he actually fights the charges, he needs to carefully consider whether he can truly afford this fight.

Innocent or guilty, the deck is stacked against him. He may be better advised to just take the sanction, spend the next two years training hard, and come back when his suspension is over. In the meantime, he’ll have all that money he would have spent on lawyers.

On the flip side, if he follows that advice and he’s innocent, the system will go unchallenged. It’s a tough choice to make, and not one for those with a weak stomach. But he may not be the only one making such a choice. To steal a line from an old song …

How long can this keep going on?

Looks like the annual ritual of doping cases that emerge on the eve of the Tour de France is well on its way to achieving Puerto-like impact on the 2009 edition of cycling’s most storied race. That is, this report is to be believed.

L’Equipe is reporting (at least, that’s what a number of other news agencies are saying, but good luck finding the article on the L’Equipe web site) that there could be between four and seven doping cases to emerge between now and the time the Tour begins in Monaco a couple of days hence. The cases, which are not based on the UCI’s biological passport program, apparently stem from samples collected during the Tour of Romandie and the Tour de Suisse.

So far, the names of riders affected by the rumored test results have not been identified in print. So it’s unclear if the alleged miscreants are big names within the sport, or domestiques working for the big names. Either way, if the report is true, a number of teams may be reshuffled within the next couple of days.

[Post to Twitter] Tweet This Post 

Dekker Ousted From Silence-Lotto Tour Squad

Looks like Thomas Dekker is in a whole heap o’ trouble today. Based on retesting of an out-of-competition sample given in December 2007 and on data aquired as a result of the UCI’s biological passport program. It appears that Dekker tested positive for EPO. The Daily Peloton is reporting that he tested positive for Dynepo, a second-generation form of the blood boosting drug. As Bart Hazen reports:

The nature of Mr Dekker’s haematological profile prompted the UCI to conduct a detailed review of the results of EPO analyses conducted on urine samples taken from him since the commencement of the biological passport programme. As part of this review, the UCI requested the WADA accredited laboratory in Cologne to re-examine the results of a urine sample collected from Mr Dekker in December 2007. On 30 June 2009, the Cologne laboratory reported a finding of recombinant EPO (Dynepo) in this sample. This result was reported in accordance with new EPO detection and reporting rules approved by the World Anti-Doping Agency in May 2009.

Yahoo! Sport/Eurosport (hat tip to Jeff for the link) notes:

“We have learnt on Wednesday morning that new tests… on samples from December 24, 2007, have proved positive for EPO,” his Silence-Lotto team said on their website.

“He (Dekker) has been immediately put on a list of ‘non-active’ riders,” said sports director Marc Sergeant.

At the time of the test, Dekker was riding for the Rabobank team.

Interesting that Dekker is accused of using EPO as a result of a December 2007 test. Although the blood cells that would be manufactured as a result of EPO use can be in the body for a long time, December is the off-season, and it seems odd to be using that particular drug at that particular time. Sure, those extra blood cells would be around at the beginning of the season, but given that the urine test can only see that particular form of EPO for a few days after it’s been administered, what was the point? Why not use it closer to the beginning of the season and maximize the benefit during competition?

I suppose that one argument in favor of using the drug at that time is that it would allow him to train harder, so there might be some benefit. Still, I find the timing of when he was using the drug to be unusual.

One thing to check, for someone who’s so inclined, would be what Dekker’s racing schedule was for the early part of 2008. Was he in any races during January 2008 or early February 2008? If so, that might explain the temptation to use EPO in December 2007. If not, then one has to wonder (assuming that the accusations are true, which they may not be), “What was he thinking?”

The timing of today’s announcement is interesting, too. It’s probably just a coincidence that this story came out just a few days before the 2009 Tour de France starts in Monaco, right? (Or, more to the point, it seems to be part of the now-annual ritual of offering up a doping sacrifice in the final days before le Tour begins.)

Dekker faces at least a two-year ban from cycling if he’s found guilty of using EPO. Meanwhile, Charley Wegelius, a Briton, will replace Dekker in the Silence-Lotto lineup.

More coverage of Dekker’s positive test result can be found at:

The New York Daily News
Agence France Presse
CyclingNews.com
VeloNews.com

[Post to Twitter] Tweet This Post 

Another Monday, Another Roundup

With the Grand Depart just five days away, it’s time for a couple of Tour-related items. And maybe we’ll throw in a couple of other random musings. First up …

Do Ya Feel Lucky? Well, Do Ya … ?

What would the start of the Tour de France be without various sports writers and pundits taking their guesses at who’s in a position to win the Tour. Well, over at Smithers MINNEAPOLIS, you can take your own shot at pro cycling prognostication as part of his 2009 Tour de France pool. Study the rosters of the various teams (CyclingNews.com is a good resource, as is the official TdF web site – once they’ve posted the team rosters) and take your best shot at who’s going to win, show and place — along with who will win the various jerseys and who will win a number of stages within the Grandest of the Grand Tours. Entries are due by 11:59 p.m. Central time on July 3rd.

Chris Horner Explains

For those who weren’t following the comments on the previous post, here’s the scoop on Chris Horner and why he isn’t headed across the pond right now. In a blog posting at OregonLive.com, pro cyclist Chris Horner explains how it came to pass that he was left off the 2009 Astana Tour de France squad. In a word, “politics.” As Horner recounted:

Like everything you do in life, politics exist even in cycling. And, like in every other aspect of life, they limit the power people have to make decisions. As a result, Johan’s hands were tied.

It was always going to be a difficult decision, with so many interests weighing in on the nine precious roster positions.

One spot would go to a Kazakh, for the sponsors. Dmitriy Muravyev got it.

Four would go to our top GC riders — Alberto Contador, Lance Armstrong, Levi Leipheimer and Andreas Kloden — all of whom have finished on the podium at the Tour.

Two went to Haimar Zubeldia and Yaroslav Popovych, who were selected early as support riders.

The eighth spot went to Gregory Rast, a big guy who could help tackle the flats.

That left one final spot — the spot I had believed to be mine.

But instead, Alberto, whom the team was being built around, wanted to take one of his “boys” with him as a support rider. So Sergio Paulinho was in and I was suddenly the odd man out.

After the call I did what I always do when things are going badly; I rode my bike.

The next day, we got everything loaded up, and I thanked Lance and Levi for their efforts to get me on the team, since they both did more than their fair share of lobbying on my behalf. I thanked Lance once again for putting me up in a great place in Aspen to train with him and Levi, not to mention the great racing in Nevada City, Calif., last Sunday.

Horner’s account is remarkable for the graciousness in how he writes about what must be a bitter disappointment. In closing his post, Horner notes:

Before I go I would like to thank Johan again for his efforts. Don’t be too hard on him — he has a difficult job and was stuck in an impossible position. Everybody has to make hard decisions sometimes, and in that situation it’s impossible to make everyone happy. This time I’m sure he’s not the one at fault, and I appreciate all he has done for me in the two years that I have been with the team.

Sometimes things have to be done because the people paying the bills say so, and sometimes things are out of our control. As Chris Horner said, politics even exists in cycling.

Meanwhile, Out in California

According to a press release from the OUCH Pro Cycling Team Presented by Maxxis:

Benicia, CA – As John Murphy of the OUCH Pro Cycling Team Presented by Maxxis noted after the Cytomax Benicia Criterium, “you don’t want to leave empty handed from a race sponsored by one of your sponsors.”

Murphy took this race by the hands and came away with the win after attacking out of a small break with four laps to go and soloing in for the victory on an afternoon where temperatures hovered around the 100-degree mark.

Murphy and teammate Roman Kilun helped make the race early, joining a 12-rider lead group just a handful of laps into the 60-minute race that would prove to be the decisive move.

With a number of top teams represented in the break, and packing plenty of horsepower, the front group steadily extended its gap to the peloton, eventually gaining 0:50 on the main bunch. With about a dozen laps remaining, the break splintered, with five riders up front group, including Murphy and Kilun along with Scott Swizanski (Kelly Benefit Strategies) and a resurgent Chad Gerlach (Amore e Vita).

They steadily gained on their former break-mates, while former team member Mike Sayers (Amgen) spearheaded a chase out of the peloton marked by Floyd Landis of OUCH Presented by Maxxis. While the chase closed the gap a bit, they never threatened the lead group, leaving the five riders to contest the closing laps for the win.

As the five-rider group closed in on the back end of the main peloton, Bobby Lea of OUCH Presented by Maxxis dropped back to the back end of the main bunch and paced his two teammates, as well as the other members of the break, to the front of the bunch. Within a lap, the break was once again clear of the peloton! .

On the fifth lap from the end, Swizanski put in a dig which Gerlach covered. When that came back, Murphy dove the first left-hander after crossing the start/finish line and drove it. The sprinter, also known to be a strong time trialist, put his engine to work and opened a 10-second gap with two laps remaining.

Swizanski and Gerlach were leading the chase while Kilun covered. Murphy went into the bell lap holding a five-second lead, with a highly motivated Gerlach trying to shut it down. Coming out of the final turn, Murphy was hanging on to a two-second lead, with Gerlach starting to close on the 300-meter, slightly uphill drag to the line. Murphy took a quick look behind him and dug deep for one last effort over the final 150 meters, holding off Gerlach by several bike lengths, while Swizanski came home in 3rd place. Kilun rolled in for 5th.

“I saw Gerlach coming after the last turn and I just put my head down and went one last time,” Murphy said. “I was really glad I had Cytomax in me today.”

[Post to Twitter] Tweet This Post 

Alberto’s Power Play?

Interesting happenings in Team Astana land. Today they announced their Tour de France lineup. Nine riders, with four strong contenders for the overall general classification.

Lance Armstrong

The legendary seven-time winner might seem the natural pick for team leader. Armstrong certainly isn’t lacking for competitive fire in the belly with his return to professional cycling. And now that he’s tasted his first win for the season (Nevada City), he might have a thirst for more victories. The only question is: Does Armstrong have the form to dominate the Tour like he did in days of old? From his results so far this season, he’s certainly coming into the kind of fitness he needs to compete in cycling’s equivalent of the Super Bowl. Armstrong is definitely one to keep an eye on this year, and he’ll certainly draw more spectators and fan interest — especially on this side of the pond. Whether he’s a podium contender will become more clear as the race develops.

Levi Leipheimer

Leipheimer is a true workhorse, and a cyclist capable of performing quite well at the Tour. In his last appearance, he managed to land on the third podium step, with a certain teammate of his standing at the top. Last year, he placed second at the Vuelta while helping that same teammate win the overall title. Leipheimer is a strong time-trialist and a very good all-around cyclist. Were it not for the presence of certain other riders on the Astana squad, he would be a shoe-in for team leader. Given his age, he’s reaching the end of his career, so his opportunities to stand on the top step of the podium will be fewer and fewer as whatever remains of his professional career goes by.

Andreas Klöden

Klöden, like Leipheimer, is a rider who arguably could win a Grand Tour at some point during his career. Unfortunately for his own chances, he’s often played the domestique to other star riders. This year, he finds himself in another “always the bridesmaid, never the bride” situation, working to support Astana’s annointed leader. But, should something untoward happen to the designated rider(s), Klöden — like Leipheimer — could still be a contender. Perhaps someday he’ll ride for a team built around himself rather than others. Better do it soon, though, because the timespan for a career in pro cycling doesn’t go on forever.

Alberto Contador

Lance Armstrong may be the ghost of Tours past. And Levi Leipheimer and Andreas Klöden may be the ghosts of Tours present. Alberto Contador is the ghost of future Tours, as well as the 2007 Tour winner. Having performed a hat trick by winning the next two Grand Tours he entered, Contador is one of the very few who have won three consecutive Grand Tours. The young Spaniard comes into the 2009 edition of the Tour as a strong contender for the overall title, and according to today’s announcement on the Team Astana web site, he will be the team’s designated leader. (CyclingNews.com has a story that suggests that Armstrong and Contador will be co-leaders, but the team’s official announcement doesn’t appear to make that statement.) No matter how long Lance Armstrong’s comeback to professional cycling lasts, it’s a good bet that Contador will be competing long after Lance retires once and for all. And it’s a good bet he’ll be a strong Tour contender for some time to come.

Although Armstrong had a strong performance at the Giro d’Italia (12th), he hasn’t yet demonstrated the old patron-like dominance of his earlier days. It would be dangerous to write his chances off, however. And, it could even be that Bruyneel’s real plan is to make Contador appear to be the leader only to draw other teams’ attention away from Big Tex. Still, Alberto has the chops to win the race, though his previous win came in part due to the sudden removal of Michael “The Chicken” Rasmussen  just days before the 2007 Tour ended. Once he gained the yellow jersey in 2007, Contador had to fend off Cadel Evans’ attempt to wrest the jersey from him. Evans couldn’t quite pull it off, however. So it would be fair to say Contador earned his victory, despite Rasmussen’s untimely departure.

The timing of Astana’s announcement is quite the coincidence, what with Joe Lindsey’s article yesterday suggesting that Garmin/Slipstream had discussions with Alberto Contador about joining their team in the event that the Astana sponsors didn’t make good on their commitments. If that had happened, the team would have likely scattered to the wind, leaving Contador and the rest of the crew looking for teams for the remainder of the season. (Lindsey also reports that Armstrong and Bruyneel had already put together the groundwork for a Livestrong-Nike team to be born out of Astana’s ashes as well. So at least some of Astana’s riders would have been employed if the current sponsors reneged on their obligations.)

Jonathan Vaughter’s discussions with Contador may point to a possible defection at the end of the 2009 season, when the Spanish rider’s contract with Astana reaches its end. Or, it could lead Bruyneel and company to renew their arrangement with Contador at a higher salary. Either way, it was a shrewd move. One has to wonder if it also helped tip the scales in his favor, when it came time to deciding who the team’s leader would be for this year’s Grand Boucle.

And, if what Lindsey reports is true, one has to wonder whether there are any internal divisions in the Astana squad. If so, there may be some added drama in France this summer, as Armstrong and Contador relive a La Vie Claire moment. A blast from the past, 1986 style. (Just ask Greg LeMond what that was like…)

And speaking of JV and Garmin/Slipstream…

Today’s Denver Post has an interesting article. It turns out that the Boulder,Colorado-based team is making a bit of Tour de France history in the 2009 race. Their Tour roster is the first filled completely with riders from English-speaking countries, according to the Post. I’m not so sure that claim is correct. There may have been one or two fully English-speaking teams back in the 1960s, around the time of Tommy Simpson’s ill-fated ride up Mount Ventoux.

[Post to Twitter] Tweet This Post 

Monday Roundup

A different take on baseball’s doping challenges

Zev Chafets in The New York Times offers up an interesting point of view about the use of performance-enhancing drugs in baseball. The headline to Chafets’ article, Let Steroids Into the Hall of Fame, pretty much sums up what he has to say. In his op-ed piece, Chafets notes:

Since the dawn of baseball, players have used whatever substances they believed would help them perform better, heal faster or relax during a long and stressful season.

Rewrite that sentence a bit and you could apply it to almost any other sport, or even sports in general. Fact is, performance-enhancement through drugs and/or other methods has been around as long as competitive sports. It’s a part of human nature that some will try to find ways to get a leg up on their competition. He goes on to observe that:

On any given day, the stands are packed with youngsters on Adderall and Ritalin (stimulants used to treat attention deficit hyperactivity disorder) and college students who use Provigil (an anti-narcolepsy drug) as a study aid. The guy who sings the national anthem has probably taken a beta blocker to calm his stage fright. Like it or not, chemical enhancement is here to stay.

Yes, I’m afraid that the use, and sometimes overuse, of various medications is almost endemic in our society. Performance-enhancement for the masses is not going away any time soon. Chafets ends his piece by saying:

If [the Baseball Hall of Fame] surrenders to the moralists who want to turn back the clock to some imagined golden era, and excommunicates the greatest stars anyone has ever seen, it will suffer the fate of all battlefields located on the wrong side of history. Obscurity.

Chafets certainly has an interesting take on the subject. Roland S. Martin’s recent column at CNN.com offers a similar point of view.

OK, got it. Baseball had a terrible drug problem. Now they have a drug testing plan in place that has some teeth in it. So, can we just move the hell on?

All of baseball pulled a Robert Johnson, as in the legend of the classic blues singer who supposedly got his gift for music by making a pact with the devil. Or maybe more like Judas. The sport turned in its integrity for a few pieces of silver.

Let’s just accept this as a fact, acknowledge those were the dark days and move on. It’s just tiring to keep going back to what happened then. It’s done. It’s over. So let it go.

There are those who won’t let it go, however. But if we did  just “let it go,” will we even learn something from the whole experience? At a certain point, it’s right to move on. Has professional baseball and its fans reached that point? I don’t know.

Tilting at windmills?

Alejandro Valverde filed an appeal last week to overturn the Italian Olympic Committee’s (CONI’s) two-year ban imposed as a result of the Spanish cyclist’s alleged ties to Operacion Puerto. In a press release issued by the Court of Arbitration for Sport, Valverde asks the CAS to rule that CONI had no jurisdiction in pursuing a case against him, and to lift the sanction imposed by CONI.

Going by the usual WADA/UCI results management rules, the Spanish cycling federation (RFEC) should be the agency to prosecute Valverde for any violations regarding Operacion Puerto — unless Valverde is licensed through a different federation. (Which was the case with Michael Rasmussen, who was licensed through Monaco’s cycling federation, rather than the Danish Cycling Union.) If the RFEC refused to do so, despite evidence of Valverde’s involvement, then perhaps the UCI or WADA could take the matter up with the Court of Arbitration for Sport. 

CONI’s claim of authority stems from a blood test taken during the 2008 Tour de France, when the race ventured onto Italian soil for a day. Supposedly, the DNA from that sample matches DNA from a blood bag taken from Dr. Eufemiano Fuentes’ office during the Puerto investigation. Assuming this is true, it would still be up to the RFEC to prosecute Valverde.

The question to be answered is whether or not the CAS will agree that CONI has the authority to go after Valverde. Depending on how the body rules, the UCI may or may not be able to institute a world-wide ban, as Pat McQuaid has indicated he might do after reviewing CONI’s case.

Under the existing rules, the issue seems pretty clear-cut. But that doesn’t mean the ruling will be. Currently, the CAS has not given any indication when or where Valverde’s case will be heard.

The Saga of Vladimir Gusev

Back in July 2008, Vladimir Gusev was fired by the Astana cycling team for what were reported to be “irregular test values.” As Agence France Presse reported in an article on July 25, 2008:

The three-time Russian time-trial champion showed “abnormal values” during an internal doping check, according to the release.

Though the results “do not indicate the use of banned substances,” the release continued, “the team has therefore applied the contractual terms based on these physiological and biological abnormalities,” dismissing Gusev “with immediate effect.”

The CAS ruled last week that Astana should not have fired Gusev based on the Russian rider’s results. Astana will also have to pay Gusev his salary, as well as damages and legal costs.

Given that Astana’s own announcement of Gusev’s dismissal noted that the rider’s test results didn’t indicate the use of banned substances, one has to wonder exactly what reason Astana let Gusev go. Apparently, whatever the reason, the CAS panel decided that Astana should not have taken the action they did.

No announcement and no written ruling in Gusev’s case is currently available on the CAS’s web site, which makes the the arbitration panel’s reasoning a bit of a mystery. Maybe at some point the CAS panel will release their full decision. But don’t bet on it.

And finally…

Strange things turn up in Google ads. Apparently, Microsoft is advertising their Bing.com search engine using their competitor’s ad placement service. I saw this on VeloNews.com just a bit ago, when I was researching Vladimir Gusev.

Bing ad via Google

Bing ad via Google

[Post to Twitter] Tweet This Post 


Rant 2.0 Launches


Politics@Rant, also known as Rant2.0, launched on January 10th. It's a place where the discussion focuses on politics, the economy and current events. When you get a chance, hop on over and check it out.

Rant's New Book


Available From Amazon.com

Also available from Barnes & Noble.com, or you can order from directly from my publisher (Greenwood Press/Praeger).


Rant On NPR

Hear Rant being interviewed on the WUWM show Lake Effect.

To listen to the other segments from this episode of Lake Effect, click here.


Search RYHO

Rant on Twitter

Calendar

July 2009
M T W T F S S
« Jun    
 12345
6789101112
13141516171819
20212223242526
2728293031  

Help Send Bikes To Africa

Reader Chris Grimes sent me a link to DOUBLEbikeMATCH, a web site of World Bicycle Relief, a nonprofit organization that provides access to independence and livelihood through The Power of Bicycles®. They have an "angel donor" this year who will match all donations – dollar for dollar – up to $750,000.

If you're looking to make some charitable donations before the end of the year, here's a good way to help make a difference.

For more information, visit the DOUBLEbikeMATCH web site.

Help support this site, shop the RYHO Amazon Store

Categories

MyFreeCopyright.com Registered & Protected


'
' -->

© 2006-2009 Rant Your Head Off All Rights Reserved -- Copyright notice by Blog Copyright

Tweet This Post links powered by Tweet This v1.3.9, a WordPress plugin for Twitter.